Pair Name	Resveratrol, Docetaxel
Disease Info	[ICD-11: 2C82]	Prostate cancer		Investigative
Biological Phenomena	Induction-->Necroptosis
Gene Regulation	Up-regulation	Phosphorylation	ATM	hsa472
	Up-regulation	Phosphorylation	ATR	hsa545
	Up-regulation	Phosphorylation	H2AX	hsa3014
In Vitro Model	LNCaP	Prostate carcinoma	Homo sapiens (Human)	CVCL_0395
Result	We report resveratrol as an adjuvant drug candidate for improving the outcome of treatment in DTX therapy. Although the underlying mechanisms of necroptosis should be investigated comprehensively, targeting apoptosis and necroptosis simultaneously in the treatment of cancer can be a useful strategy for the development of promising drug candidates.